BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and commercializing transformative treatments for patients with serious immunologic diseases, today announced it will host an in-person R&D day featuring Richard Lafayette, M.D., FACP, from Stanford University Medical Center, who will join company management to present Phase 2b eGFR and proteinuria data from week 72 of the ORIGIN Phase 2b clinical trial of atacicept for the treatment of IgA nephropathy (IgAN), and Jonathan Barratt, Ph.D., FRCP, from the University of Leicester for a discussion of the results, on January 25, 2024.

加利福尼亚州布里斯班，2024年1月8日（环球通讯社）--Vera Therapeutics，Inc.（纳斯达克代码：Vera），一家为严重免疫性疾病患者开发和商业化转化治疗的晚期临床生物技术公司，今天宣布将举办一场由斯坦福大学医学中心医学博士Richard Lafayette亲自参与的研发日，2024年1月25日，世卫组织将与公司管理层一道提交阿塔西普治疗IgA肾病（IgAN）的ORIGIN 2b期临床试验第72周的2b期eGFR和蛋白尿数据，以及莱斯特大学的乔纳森·巴拉特（JonathanBarratt）博士（FRCP）对结果进行讨论。

To register, click here. Presentation Details:    Date: Thursday, January 25, 2024 Time: 8:00 AM ET Location: Lotte New York Palace Hotel, 455 Madison Ave, New York, NY 10022 United States Webcast: https://lifescievents.com/event/veratx/ About Richard Lafayette, M.D., FACP Dr. Lafayette is a Professor of Medicine (Nephrology) and Director of the Stanford Glomerular Disease Center at Stanford University Medical Center.

要注册，请单击此处。演示细节：日期：2024年1月25日星期四时间：美国东部时间上午8:00地点：纽约麦迪逊大道455号乐天纽约宫酒店，纽约10022美国网络广播：https://lifescievents.com/event/veratx/关于医学博士Richard Lafayette，FACP Lafayette博士是斯坦福大学医学中心的医学教授（肾脏病学）和斯坦福肾小球疾病中心主任。

Dr. Lafayette completed his medical education at New York Medical College and went on to complete his residency at the Long Island Jewish Medical Center, and his fellowship at Stanford University School of Medicine. Dr. Lafayette is board-certified in Internal Medicine and Nephrology. Dr. Lafayette served as the Associate Chair of the Stanford University Department of Medicine from 2002 to 2007, the Clinical Chief of Nephrology at Stanford University from 1999 to 2012, and currently serves as the Director of the Stanford Glomerular Disease Center since 2010.

拉斐特博士在纽约医学院完成了医学教育，并在长岛犹太医学中心完成了住院治疗，并在斯坦福大学医学院获得了奖学金。拉斐特博士拥有内科和肾脏病学委员会认证。拉斐特博士于2002年至2007年担任斯坦福大学医学系副主任，1999年至2012年担任斯坦福大学肾脏病临床主任，自2010年起担任斯坦福肾小球疾病中心主任。

Dr. Lafayette was honored in America’s Top Doctors, Best Doctors from 2004 to 2018, and received America’s Top Doctors .

拉斐特博士荣获2004年至2018年美国顶级医生、最佳医生奖，并获得美国顶级医生奖。